INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 17 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $56,000 | +33.3% | 12,036 | 0.0% | 0.00% | – |
| Q4 2018 | $42,000 | -65.3% | 12,036 | 0.0% | 0.00% | – |
| Q3 2018 | $121,000 | +39.1% | 12,036 | 0.0% | 0.00% | – |
| Q2 2018 | $87,000 | +22.5% | 12,036 | +2.4% | 0.00% | – |
| Q1 2018 | $71,000 | -37.2% | 11,751 | 0.0% | 0.00% | – |
| Q4 2017 | $113,000 | +8.7% | 11,751 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | -30.2% | 11,751 | 0.0% | 0.00% | – |
| Q2 2017 | $149,000 | -46.6% | 11,751 | +20.7% | 0.00% | -100.0% |
| Q4 2015 | $279,000 | +0.7% | 9,732 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $277,000 | -32.8% | 9,732 | -15.1% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | +33.3% | 11,458 | +115.3% | 0.00% | 0.0% |
| Q1 2015 | $309,000 | +37.9% | 5,321 | 0.0% | 0.00% | – |
| Q4 2014 | $224,000 | +8.7% | 5,321 | 0.0% | 0.00% | – |
| Q3 2014 | $206,000 | – | 5,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |